JP2010502192A5 - - Google Patents

Download PDF

Info

Publication number
JP2010502192A5
JP2010502192A5 JP2009526917A JP2009526917A JP2010502192A5 JP 2010502192 A5 JP2010502192 A5 JP 2010502192A5 JP 2009526917 A JP2009526917 A JP 2009526917A JP 2009526917 A JP2009526917 A JP 2009526917A JP 2010502192 A5 JP2010502192 A5 JP 2010502192A5
Authority
JP
Japan
Prior art keywords
boris
expression
seq
isoform
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009526917A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010502192A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/077281 external-priority patent/WO2008028066A2/en
Publication of JP2010502192A publication Critical patent/JP2010502192A/ja
Publication of JP2010502192A5 publication Critical patent/JP2010502192A5/ja
Pending legal-status Critical Current

Links

JP2009526917A 2006-08-31 2007-08-30 Borisアイソフォーム並びに疾患を検出及び治療する方法 Pending JP2010502192A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84134206P 2006-08-31 2006-08-31
PCT/US2007/077281 WO2008028066A2 (en) 2006-08-31 2007-08-30 Boris isoforms and methods of detecting and treating disease

Publications (2)

Publication Number Publication Date
JP2010502192A JP2010502192A (ja) 2010-01-28
JP2010502192A5 true JP2010502192A5 (cg-RX-API-DMAC7.html) 2010-10-14

Family

ID=38846916

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009526917A Pending JP2010502192A (ja) 2006-08-31 2007-08-30 Borisアイソフォーム並びに疾患を検出及び治療する方法

Country Status (6)

Country Link
US (2) US8206933B2 (cg-RX-API-DMAC7.html)
EP (1) EP2057469A2 (cg-RX-API-DMAC7.html)
JP (1) JP2010502192A (cg-RX-API-DMAC7.html)
AU (1) AU2007289149B2 (cg-RX-API-DMAC7.html)
CA (1) CA2662012C (cg-RX-API-DMAC7.html)
WO (1) WO2008028066A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7998486B2 (en) * 2006-10-25 2011-08-16 Newlink Genetics Corporation Enhanced immunogenicity of tumor associated antigens by addition of alphaGal epitopes
CN101821410B (zh) * 2007-08-10 2016-01-27 温德维亚集团公司 印迹位点调节物兄弟(boris)的基因沉默
EP3199627B1 (en) * 2014-09-24 2021-04-07 Sapporo Medical University Tumor antigen peptides
US10415094B2 (en) 2016-10-06 2019-09-17 HelicalHelp LLC Risk stratification method for a patient having a polymorphism
BR112021013197A2 (pt) 2019-01-24 2021-09-28 Lumus Ltd. Sistema óptico
TWI897971B (zh) 2020-06-01 2025-09-21 以色列商魯姆斯有限公司 用於近眼顯示器的虛擬影像遞送系統
CN114514460A (zh) 2020-08-23 2022-05-17 鲁姆斯有限公司 减少波导的闪烁和重影的用于图像的二维扩展的光学系统

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003072799A2 (en) 2002-02-22 2003-09-04 The Government Of The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Brother of the regulator of imprinted sites (boris)
WO2006034335A2 (en) * 2004-09-21 2006-03-30 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Method of detecting cancer based on immune reaction to boris

Similar Documents

Publication Publication Date Title
JP2007506426A5 (cg-RX-API-DMAC7.html)
US10724097B2 (en) Methods and compositions for diagnosis and management of diabetes and metabolic syndrome
EP2572721B1 (en) Pharmaceutical composition including an hif-2 inhibitor as an active ingredient for preventing or treating arthritis
JP2010502192A5 (cg-RX-API-DMAC7.html)
KR20230123458A (ko) 퇴행성 신경질환의 진단용 바이오마커
JP7177439B2 (ja) 炎症促進因子発現抑制剤、その有効成分のスクリーニング方法、該方法に有用な発現カセット、診断薬、及び診断方法
KR20220112204A (ko) 뇌의 레닌-안지오텐신 시스템 인자를 이용한 알츠하이머병의 진단 방법
KR101883936B1 (ko) 림프절 전이 예측용 마커 및 이를 이용한 림프절 전이 예측 방법
EP2307561A2 (en) Interferon epsilon (ifne1) as a marker for targeted cancer therapy
US10363322B2 (en) Non-alcoholic fatty liver regulator 14-3-3 protein
JP6507307B2 (ja) 非アルコール性脂肪肝調節因子14−3−3タンパク質
US11273161B2 (en) Methods of treating autism spectrum disorders
JP7255897B2 (ja) Alsのバイオマーカーおよびalsの診断方法
KR101128640B1 (ko) 간암 진단용 마커로서의 rps 14의 용도
WO2016031996A1 (ja) 関節炎の予防·治療剤、検査キット、並びに関節炎予防·治療薬のスクリーニング方法
CN116411080B (zh) 一种区分冷、热肿瘤的标志物
WO2015194524A1 (ja) B前駆細胞性急性リンパ芽球性白血病新規キメラ遺伝子
KR102066663B1 (ko) 유전성 말초 신경질환 진단용 마커 및 그의 용도
KR20190124469A (ko) 퇴행성 뇌신경 질환 진단용 마커 및 이의 용도
KR20120028748A (ko) Mcm7 유전자를 포함하는 간흡충 감염 또는 간암 진단용 마커
US20040138161A1 (en) Methods of modulating proliferative conditions
KR102202120B1 (ko) 알츠하이머 질환의 진단 또는 치료를 위한 Ube2h의 용도
KR20250069470A (ko) 단백질체 바이오마커를 통해 코로나바이러스 감염증의 예후를 예측하기 위한 정보제공방법
KR20250142600A (ko) 구강편평태선의 예후 예측을 위한 신규한 바이오마커 및 이의 용도
Mattioli et al. Highly clustered de novo frameshift variants in the neuronal splicing factor NOVA2 result in a specific abnormal C terminal part and cause a severe form of intellectual disability with autistic features